We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+9.52%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.26B
AUM Growth
+$258M
Cap. Flow
+$193M
Cap. Flow %
15.3%
Top 10 Hldgs %
36.86%
Holding
2,288
New
1,062
Increased
238
Reduced
222
Closed
745

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$22.9M
2
NFLX icon
Netflix
NFLX
+$14.7M
3
SNOW icon
Snowflake
SNOW
+$12.4M
4
LLY icon
Eli Lilly
LLY
+$8.58M
5
CRM icon
Salesforce
CRM
+$8.44M

Sector Composition

Rank Sector Weight
1 Communication Services 24.46%
2 Financials 17.08%
3 Technology 7.74%
4 Healthcare 6.69%
5 Consumer Discretionary 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCLI
1326
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$19K ﹤0.01%
+4,732
New +$14.2K
EVGOW
1327
DELISTED
EVgo Inc Warrants
EVGOW
$19K ﹤0.01%
63,136
+11,361
+22% +$2.72K
KULR icon
1328
KULR Technology Group
KULR
$130M
$19K ﹤0.01%
+13,095
New +$33.3K
SES icon
1329
SES AI
SES
$206M
$19K ﹤0.01%
+10,366
New +$22.4K
VNRX icon
1330
VolitionRx Ltd
VNRX
$8.61M
$19K ﹤0.01%
+1,335
New +$19.6K
BVC
1331
BitVentures Limited Ordinary Shares
BVC
$2.37B
$19K ﹤0.01%
+10,472
New +$64.2K
LKCO
1332
DELISTED
Luokung Technology Corp Ordinary Shares
LKCO
$19K ﹤0.01%
+4,806
New +$26K
IMNN icon
1333
Imunon
IMNN
$6.77M
$18K ﹤0.01%
+1,983
New +$24.2K
MGIH icon
1334
Millennium Group International
MGIH
$17.6M
$18K ﹤0.01%
+14,217
New +$19.9K
NAAS
1335
NaaS Technology Inc
NAAS
$57.1M
$18K ﹤0.01%
38
-186
-83% -$152K
HIND
1336
Vyome Holdings
HIND
$15.8M
$18K ﹤0.01%
13
+10
+333% +$15.3K
WKSP icon
1337
Worksport
WKSP
$10.9M
$18K ﹤0.01%
+1,227
New +$19.5K
XELB icon
1338
Xcel Brands
XELB
$5.77M
$18K ﹤0.01%
+1,393
New +$15K
CNSP icon
1339
CNS Pharmaceuticals
CNSP
$8.04M
0
CTM icon
1340
Castellum
CTM
$57.3M
$17K ﹤0.01%
+56,682
New +$15.3K
IGC icon
1341
IGC Pharma
IGC
$29.3M
$17K ﹤0.01%
60,723
-9,273
-13% -$2.87K
NNVC icon
1342
NanoViricides
NNVC
$34.7M
$17K ﹤0.01%
+16,721
New +$19.3K
PLUR icon
1343
Pluri
PLUR
$18.9M
$17K ﹤0.01%
+3,664
New +$16.4K
TOVX icon
1344
Theriva Biologics
TOVX
$10.6M
$17K ﹤0.01%
+1,565
New +$19.3K
VFF icon
1345
Village Farms International
VFF
$297M
$17K ﹤0.01%
22,373
-100,207
-82% -$76.4K
OPGN
1346
DELISTED
OpGen, Inc
OPGN
$17K ﹤0.01%
+4,038
New +$21.5K
FRMM
1347
Forum Markets
FRMM
$82.6M
$16K ﹤0.01%
401
+322
+408% +$22.6K
CLRO icon
1348
ClearOne Inc
CLRO
$17M
$16K ﹤0.01%
+1,005
New +$11.4K
PLBY icon
1349
Playboy Inc
PLBY
$163M
$16K ﹤0.01%
15,576
-12,909
-45% -$8.49K
REFR icon
1350
Research Frontiers
REFR
$17.2M
$16K ﹤0.01%
+16,298
New +$16.9K

Similar funds

Virtu Financial's Q4 2023 Portfolio in Review

As of Q4 2023, Virtu Financial held 2,288 positions worth $1.26B, up 26% from $1.01B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Virtu Financial deployed $193M of net new capital in Q4 2023, opening 1,062 new positions and adding to 238 existing holdings. Its largest new stake was State Street Technology Select Sector SPDR ETF: 304,340 shares worth $29.3M.

By sector, the portfolio is most concentrated in Communication Services at 24% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Microsoft, an estimated $22.9M trimmed.

  • Virtu Financial's largest Q4 2023 buy was State Street Technology Select Sector SPDR ETF: 304,340 shares worth $29.3M.
  • Virtu Financial added most to Alphabet (Google) Class A in Q4 2023, an estimated $109M increase.
  • Virtu Financial's biggest Q4 2023 reduction was Microsoft, cutting an estimated $22.9M.
  • Virtu Financial fully exited Eli Lilly in Q4 2023, selling an estimated $8.58M.
  • Virtu Financial's ten largest holdings make up 37% of its $1.26B portfolio in Q4 2023.
  • Virtu Financial opened 1,062 new positions and closed 745 in Q4 2023.
  • Virtu Financial's portfolio value rose 26% quarter-over-quarter to $1.26B.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.